4//SEC Filing
ORBIMED ADVISORS LLC 4
Accession 0000947871-25-000854
CIK 0001699382other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:09 PM ET
Size
8.1 KB
Accession
0000947871-25-000854
Insider Transaction Report
Form 4
ORBIMED ADVISORS LLC
10% Owner
Transactions
- Sale
Common Stock
2025-09-10$1.80/sh−500,000$900,000→ 5,975,291 total(indirect: See Footnotes)
OrbiMed Capital GP V LLC
10% Owner
Transactions
- Sale
Common Stock
2025-09-10$1.80/sh−500,000$900,000→ 5,975,291 total(indirect: See Footnotes)
Footnotes (2)
- [F1]These securities are held of record by OrbiMed Private Investments V, LP ("OPI V"). OrbiMed Capital GP V LLC ("GP V") is the general partner of OPI V, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment advisor under the Investment Advisors Act of 1940, as amended, is the managing member of GP V. By virtue of such relationships, GP V and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI V.
- [F2]This report on Form 4 is jointly filed by OrbiMed Advisors and GP V. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1943, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
PMV Pharmaceuticals, Inc.
CIK 0001699382
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001055951
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 5:09 PM ET
- Size
- 8.1 KB